Fundz

Anaconda Biomed Names Trent Reutiman as CEO, Replacing Francois Salmon

PRIVATEJan 07, 2025

Position

Chief Executive Officer

Company

Anaconda BioMed

Trent Reutiman
BarcelonaBiotechnologyHealth CareMedicalMedical Device

Description

Anaconda Biomed has announced the appointment of long-time medtech executive Trent Reutiman as its new CEO, replacing Francois Salmon. Reutiman brings extensive leadership experience in vascular technologies and will establish a new footprint for the company in the U.S. as it works towards regulatory approval of its ANA5 Advanced Neurovascular Access™ (ANA Funnel Catheter Technology).

Quick answer

Anaconda Biomed Names Trent Reutiman as CEO, Replacing Francois Salmon (January 7, 2025). Anaconda BioMed is based in Barcelona, Catalonia, Spain.

Who is the new Chief Executive Officer at Anaconda BioMed?
Anaconda BioMed named Trent Reutiman Chief Executive Officer, announced January 7, 2025.
What did Anaconda BioMed announce on January 7, 2025?
Anaconda Biomed has announced the appointment of long-time medtech executive Trent Reutiman as its new CEO, replacing Francois Salmon. Reutiman brings extensive leadership experience in vascular technologies and will establish a new footprint for the company in the U.S. as it works towards regulatory approval of its ANA5 Advanced Neurovascular Access™ (ANA Funnel Catheter Technology).
What does Anaconda BioMed do?
Anaconda Biomed is an innovative medical technology company dedicated to developing next-generation thrombectomy systems for the treatment of ischemic stroke.
Where is Anaconda BioMed based?
Anaconda BioMed is based in Barcelona, Catalonia, Spain.
Which similar companies made leadership changes around the same time?
LivaNova (January 6, 2025), Intuitive Surgical (January 3, 2025), DeepSight Technology (January 14, 2025) and Freudenberg Medical (January 15, 2025) also announced leadership changes within 45 days of Anaconda BioMed.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Medical Device

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Anaconda BioMed, and when

A new leader at Anaconda BioMed brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Anaconda BioMed raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Anaconda BioMed, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Anaconda BioMed. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Anaconda BioMed

Location

Barcelona, Catalonia, Spain

About

Anaconda Biomed is an innovative medical technology company dedicated to developing next-generation thrombectomy systems for the treatment of ischemic stroke. At the heart of its product portfolio is the ANA Funnel Catheter.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Anaconda BioMed changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Inyaki
Senior decision-maker at this company
••••••••@••••••••

See Inyaki's verified email →

Ofir
Senior decision-maker at this company
••••••••@••••••••

See Ofir's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Anaconda BioMed's next move

Learn about Strategic plan

Anaconda BioMed changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.